Franco Kraiselburd presenting Poseidon at the product launch

Franco Kraiselburd

Founder & CEO of Asclepii

A decade in regenerative medicine — and just getting started. Building Asclepii to make healing accessible to everyone, everywhere.

A journey from São Paulo to Cleveland
About Franco

A journey from São Paulo to Cleveland

Early Passion for Healing

Born in Boston and raised across South America and Europe, Franco discovered his passion for regenerative medicine at just 13 years old while studying in Brazil. His mentor introduced him to the groundbreaking work of Dr. Arnold Caplan at Case Western Reserve University. This research would shape his entire career path.

Leading Asclepii's Mission

Today, at 24, Franco leads Asclepii with a clear mission: make advanced wound care accessible to everyone, everywhere. A decade after his first days in a Cell & Molecular Biology lab under Dr. Ana Claudia Oliveira Carreira at the University of São Paulo, that promise has grown into a company now healing thousands of patients across hundreds of provider networks — united by a shared belief that healthcare should be built on wellness, not profit.

"All I know is that I know nothing. And I'm totally fine with it."

Franco Kraiselburd in the lab

Poseidon, in action

The product already helping doctors save lives today.

Building Asclepii
The Company

Building Asclepii

Named after the Greek god of medicine—"the healer of all wounds"—Asclepii is pioneering the next generation of regenerative materials. We are committed to revolutionizing wound care treatment globally. Our approach combines cutting-edge biotechnology with practical clinical solutions.

5,400+
Patients Healing with Poseidon
$3M
Raised to Date
12
Products in the Pipeline
3
FDA-Cleared Products
12
Countries in the Network

The Current Chapter

Poseidon, at scale

We're expanding Poseidon's reach — new packaging and a national footprint — so it can reach the patients who need it most.

Athena, launching soon

Our FDA-cleared spray is entering the market — indicated for eczema, in a simple, accessible format.

Artemis, getting smarter

The Artemis platform keeps getting smarter — the early foundation for what regenerative medicine becomes next.

Learn More About Asclepii
Poseidon Nanosilver Hydrogel ingredient breakdown
In Action
Highlights

In Action

Poseidon Launch Event

Poseidon Launch Event

Presenting Asclepii's FDA-cleared wound care innovation

MIT TR Innovators Under 35

MIT TR Innovators Under 35

Speaking at MIT Technology Review LATAM 2024

Research & Development

Research & Development

Leading innovation in partnership with the Center for Modular Manufacturing of Structural Tissue (CM2OST) at CWRU

News & Features
In The Press

News & Features

FeaturedEl Día (Argentina)• December 2024

Invento de raíz platense: Artemis promete salvar vidas

El ingeniero biomédico Franco Kraiselburd elaboró un innovador parche de regeneración celular que cura lesiones al impulsar la reparación de la piel lastimada. Distinguido por el MIT Technology Review.

Read Full Article
Franco Kraiselburd in the lab - El Día feature
Franco Kraiselburd presenting
Speaking

Keynotes & Speaking Engagements

Franco brings real-world insights on regenerative medicine, biotech innovation, and the future of healthcare to conferences, universities, and corporate events worldwide.

Regenerative MedicineBiotech Innovation
Let's Connect
Get In Touch

Let's Connect

Interested in discussing regenerative medicine, healthcare innovation, speaking engagements, or potential collaborations? Send a message.

Help Me Make Regenerative Medicine Massive

Help Me Make Regenerative Medicine Massive

Interested in regenerative medicine, healthtech entrepreneurship, or just want to say hello? Reach out on LinkedIn.

Franco KraiselburdFounder & CEO, Asclepii
Cleveland, Ohio🇺🇸 🇦🇷 🇧🇷